Insights from the Pan Pacific Lymphoma Conference

Videos

Innovation and the Future Development of Cell Therapies for Patients With B-Cell Lymphomas

08/05/2024

At the 2024 Pan Pacific Lymphoma Conference, Nirav Shah, MD, discusses innovation and the future development of cell therapies for patients with various types of B-cell malignancies.

At the 2024 Pan Pacific Lymphoma...

08/05/2024

Oncology

Conference Coverage

CAR T-Cell Therapy as New Standard of Care for Patients With Early Relapsed Large B-Cell Lymphoma

07/23/2024

Jason Westin, MD, shares expert insight regarding CAR T-cell therapy as standard of care treatment for patients with early relapsed large B-cell lymphoma at the 2024 Pan Pacific Lymphoma Conference.

Jason Westin, MD, shares expert...

07/23/2024

Oncology

Conference Coverage

Analyzing Evolution and Difference in the Latest Classifications of Lymphoma

07/16/2024

At the 2024 Pan Pacific Lymphoma Conference, Elaine Jaffe, MD, analyzes the differing classification systems of lymphoma, focusing on diffuse large B-cell lymphoma, follicular lymphoma, and small B-cell neoplasms.

At the 2024 Pan Pacific Lymphoma...

07/16/2024

Oncology

Conference Coverage

Potential Role of Dose-Adjusted EPOCH-R in the Frontline Setting Among Patients With Aggressive B-Cell Lymphomas

07/15/2024

Mark Roschewski, MD, shared expert insight on the possible role of dose-adjusted EPOCH-R as first-line treatment for patients with aggressive B-cell lymphomas.

Mark Roschewski, MD, shared...

07/15/2024

Oncology

Insights from the Pan Pacific Lymphoma Conference

About the Pan Pacific Lymphoma Conference

Specialties

Events

Year Round Education

HMP Global Products